Last updated: 11/07/2018 19:32:40
Randomised, DB, PC, PG Single Attack study to Evaluate the onset of efficacy of a new formulation of Sumatriptan Tablets 50mg and 100mg in the Acute Treatment of Migraine
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Randomised, DB, PC, PG Single Attack study to Evaluate the onset of efficacy of a new formulation of Sumatriptan Tablets 50mg and 100mg in the Acute Treatment of Migraine
Trial description: Randomised, DB, PC, PG Single Attack study to Evaluate the onset of efficacy of a new formulation of Sumatriptan Tablets 50mg and 100mg in the Acute Treatment of Migraine
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
C. Dahlöf; R. Cady; A.C. Poole; J. Brandes; C. Few; M. Jones. Speed of Onset and Efficacy of Sumatriptan Fast-Disintegrating/ Rapid-Release Tablets: Pooled Results of Two Replicate, Randomised, PlaceboControlled Studies. Headache Care 2004;1(4):277-280
Headache recurrence with sumatriptan fast disintegrating tablets: results from two double-blind, placebo-controlled trials. Dahlof, C., Taylor, F. R., Mulleners, W., Adelman, J., Webster, C. J., and Few, C. 9th European Federation of Neurological Societies Congress 9/17/2005 Athens; Greece
Headache recurrence with sumatriptan fast disintegrating tablets: results from two double-blind, placebo-controlled trials. Dahlof, C., Taylor, F. R., Mulleners, W., Adelman, J., Webster, C., and Few, C. 12th Congress of the International Headache Society (IHC) 10/9/2005 Tokyo; Japan
Migraine-free data with sumatriptan fast disintegrating tablets: results from two double-blind, placebo-controlled trials. Dahlof, C., Taylor, F. R., Mulleners, W., Adelman, J., Webster, C. , and Few, C. 12th Congress of the International Headache Society (IHC) 10/9/2005 Tokyo; Japan
R. Cady; J. Adelman; F. Taylor; G. Boudreau; C. Few; C. Webster. Speed of Onset and Efficacy of Sumatriptan Fast-Disintegrating/ Rapid-Release Tablets: Results of a Randomised, Placebo-Controlled Study Conducted in the USA and Canada. Headache Care 2004;1(4):281-284
Sustained pain relief and sustained pain-free rates with sumatriptan fast disintegrating tablets: results from two double-blind, placebo-controlled trials. Dahlof, C., Taylor, F. R., Mulleners, W., Adelman, J., Webster, C. , and Few, C. 12th Congress of the International Headache Society (IHC) 10/9/2005 Tokyo; Japan
Medical condition
Migraine Disorders
Product
sumatriptan
Collaborators
Not applicable
Study date(s)
October 2003 to March 2004
Type
Not applicable
Phase
2/3
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2004-18-03
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website